PATVX vs. TRBCX
Compare and contrast key facts about T. Rowe Price Target 2035 Fund (PATVX) and T. Rowe Price Blue Chip Growth Fund (TRBCX).
PATVX is managed by T. Rowe Price. It was launched on Aug 19, 2013. TRBCX is managed by T. Rowe Price. It was launched on Jun 30, 1993.
Performance
PATVX vs. TRBCX - Performance Comparison
Loading graphics...
PATVX vs. TRBCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PATVX T. Rowe Price Target 2035 Fund | -0.68% | 14.12% | 10.28% | 15.63% | -16.79% | 12.51% | 15.16% | 20.62% | -6.13% | 16.13% |
TRBCX T. Rowe Price Blue Chip Growth Fund | -11.24% | 18.78% | 48.46% | 49.42% | -38.57% | 17.54% | 34.73% | 29.97% | 2.00% | 36.54% |
Returns By Period
In the year-to-date period, PATVX achieves a -0.68% return, which is significantly higher than TRBCX's -11.24% return. Over the past 10 years, PATVX has underperformed TRBCX with an annualized return of 7.91%, while TRBCX has yielded a comparatively higher 15.86% annualized return.
PATVX
- 1D
- 1.77%
- 1M
- -4.56%
- YTD
- -0.68%
- 6M
- 1.19%
- 1Y
- 12.17%
- 3Y*
- 11.18%
- 5Y*
- 5.22%
- 10Y*
- 7.91%
TRBCX
- 1D
- 3.90%
- 1M
- -5.48%
- YTD
- -11.24%
- 6M
- -10.00%
- 1Y
- 15.04%
- 3Y*
- 26.18%
- 5Y*
- 10.52%
- 10Y*
- 15.86%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PATVX vs. TRBCX - Expense Ratio Comparison
PATVX has a 0.83% expense ratio, which is higher than TRBCX's 0.69% expense ratio.
Return for Risk
PATVX vs. TRBCX — Risk / Return Rank
PATVX
TRBCX
PATVX vs. TRBCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Target 2035 Fund (PATVX) and T. Rowe Price Blue Chip Growth Fund (TRBCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PATVX | TRBCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.18 | 0.69 | +0.49 |
Sortino ratioReturn per unit of downside risk | 1.71 | 1.14 | +0.56 |
Omega ratioGain probability vs. loss probability | 1.26 | 1.16 | +0.10 |
Calmar ratioReturn relative to maximum drawdown | 1.27 | 0.76 | +0.50 |
Martin ratioReturn relative to average drawdown | 5.74 | 2.68 | +3.07 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PATVX | TRBCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.18 | 0.69 | +0.49 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.49 | 0.44 | +0.05 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.70 | 0.70 | 0.00 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.67 | 0.57 | +0.10 |
Correlation
The correlation between PATVX and TRBCX is 0.84, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
PATVX vs. TRBCX - Dividend Comparison
PATVX's dividend yield for the trailing twelve months is around 7.08%, more than TRBCX's 5.91% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PATVX T. Rowe Price Target 2035 Fund | 7.08% | 7.03% | 3.58% | 3.00% | 5.31% | 3.38% | 2.93% | 3.77% | 5.30% | 1.72% | 2.19% | 2.39% |
TRBCX T. Rowe Price Blue Chip Growth Fund | 5.91% | 5.25% | 18.16% | 3.49% | 5.87% | 9.38% | 1.19% | 0.36% | 2.44% | 2.94% | 0.67% | 3.26% |
Drawdowns
PATVX vs. TRBCX - Drawdown Comparison
The maximum PATVX drawdown since its inception was -26.76%, smaller than the maximum TRBCX drawdown of -54.56%. Use the drawdown chart below to compare losses from any high point for PATVX and TRBCX.
Loading graphics...
Drawdown Indicators
| PATVX | TRBCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.76% | -54.56% | +27.80% |
Max Drawdown (1Y)Largest decline over 1 year | -8.03% | -17.01% | +8.98% |
Max Drawdown (5Y)Largest decline over 5 years | -23.82% | -43.63% | +19.81% |
Max Drawdown (10Y)Largest decline over 10 years | -26.76% | -43.63% | +16.87% |
Current DrawdownCurrent decline from peak | -5.12% | -13.77% | +8.65% |
Average DrawdownAverage peak-to-trough decline | -4.14% | -11.35% | +7.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.96% | 4.86% | -2.90% |
Volatility
PATVX vs. TRBCX - Volatility Comparison
The current volatility for T. Rowe Price Target 2035 Fund (PATVX) is 4.06%, while T. Rowe Price Blue Chip Growth Fund (TRBCX) has a volatility of 7.01%. This indicates that PATVX experiences smaller price fluctuations and is considered to be less risky than TRBCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PATVX | TRBCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.06% | 7.01% | -2.95% |
Volatility (6M)Calculated over the trailing 6-month period | 6.46% | 13.72% | -7.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 10.87% | 23.49% | -12.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 10.82% | 24.05% | -13.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 11.36% | 22.76% | -11.40% |